Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $24.78 USD
Change Today -0.175 / -0.70%
Volume 1.3M
DYAX On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:10 PM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David J. McLachlan

Director, Chairman of Audit Committee and Member of Strategy & Science Committee, Dyax Corp.
AgeTotal Calculated CompensationThis person is connected to 30 board members in 5 different organizations across 7 different industries.

See Board Relationships
75$77,500

Background*

Mr. David J. McLachlan, also known as Dave, has been a Director of Deltagen Inc. since July 22, 2010. Mr. McLachlan has been a Director at Dyax Corp., since May 1999. He serves as a Director at HEARx Ltd; ActivBiotics, Inc. and Benten BioServices, Inc. He has been a Non Employee Director of Skyworks Solutions Inc. since 2000. He served as a Senior Advisor to the Chairman and Chief Executive Officer at Genzyme Corporation from 1999 to 2004. Mr. McLachlan served as Executive ...

Read Full Background

Corporate Headquarters*

55 Network Drive
Burlington, Massachusetts 01803

United States

Phone: 617-225-2500
Fax: 617-225-2501

Board Members Memberships*

Former Director
Director and Chairman of Audit Committee
Former Director
Director
1986-N/A
Lead Independent Director, Chairman of Audit Committee, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee
1999-Present
Director, Chairman of Audit Committee and Member of Strategy & Science Committee
1999-N/A
Former Director
2000-N/A
Former Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee
2000-Present
Lead Independent Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
2003-N/A
Former Director
2010-Present
Director

Education*

BA
Harvard University
MBA
Harvard University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$77,500
Total Calculated Compensation$77,500
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DYAX:US $24.78 USD -0.175

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jon P. Stonehouse Chief Executive Officer, President and Executive Director
BioCryst Pharmaceuticals, Inc.
$633.7K
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex-Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.2M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
$3.6M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DYAX CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.